Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Fellowship - Priority Announcement - Inflammatory Bowel Disease

University of Alberta

$45,000.00

The Interaction of Microbial Pathogens and the Intestinal Epithelial Lining: Contributions of Inflammatory Cell Death and Barrier Disruption to Inflammatory Bowel Diseases

EF 2012-13

Résumé
Our gut is comprised of a complex society inhabited by bacteria. In this world within a world, there are ten bacteria for every human cell in our body. The relationship we have with bacteria is a symbiotic one; we need the digestive machinery of the bacteria as much as it needs our daily intake of food. In healthy individuals, the intestinal tract separates the bacteria from our body with a layer of cells which are tightly bound to one another. If the cell barrier is damaged, it would cause inflammation (an increase in our body's defense which also damages healthy tissue and organs). Frequent inflammation causes a vicious cycle of damage called Inflammatory Bowel Disease. The disease can cause a loss in weight, diarrhea, and patients are at a higher risk for colon cancer, and surgery. Our laboratory has discovered that intestinal cells can interact with harmful bacteria, then die and shed from the lining (in other words a selfless suicide to save the others). This cell shedding disturbs the intestinal barrier. We have found that a released bacterial toxin and another protein can disrupt the barrier and cause cell death. We have also used an inhibitor that can promote barrier strength. By identifying bacterial proteins which can cause cell death and methods to inhibit it, we can reduce the inflammation in the intestine and lower patient visits and possibly cases of surgeries.
Programme
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
270597
Name
Alipour Misagh
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association of Gastroenterology (Oakville, Ontario)
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
The Interaction of Microbial Pathogens and the Intestinal Epithelial Lining: Contributions of Inflammatory Cell Death and Barrier Disruption to Inflammatory Bowel Diseases
Programtype2
Fellowship Programs
Orgnameinp2
University of Alberta
Cihramount2
$45,000
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Keyworddelim
Bacterial Pathogen-Cell Interaction; Confocal Microscopy; Cytokine Analysis; Epithelial Cell Shedding; Flow Cytometry; Inflammasomes; Permeability Dysruption; Pyroptosis
Abstract
Our gut is comprised of a complex society inhabited by bacteria. In this world within a world, there are ten bacteria for every human cell in our body. The relationship we have with bacteria is a symbiotic one; we need the digestive machinery of the bacteria as much as it needs our daily intake of food. In healthy individuals, the intestinal tract separates the bacteria from our body with a layer of cells which are tightly bound to one another. If the cell barrier is damaged, it would cause inflammation (an increase in our body's defense which also damages healthy tissue and organs). Frequent inflammation causes a vicious cycle of damage called Inflammatory Bowel Disease. The disease can cause a loss in weight, diarrhea, and patients are at a higher risk for colon cancer, and surgery. Our laboratory has discovered that intestinal cells can interact with harmful bacteria, then die and shed from the lining (in other words a selfless suicide to save the others). This cell shedding disturbs the intestinal barrier. We have found that a released bacterial toxin and another protein can disrupt the barrier and cause cell death. We have also used an inhibitor that can promote barrier strength. By identifying bacterial proteins which can cause cell death and methods to inhibit it, we can reduce the inflammation in the intestine and lower patient visits and possibly cases of surgeries.
Competitiondate
201210
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Alipour, Misagh
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $45,000~ $0~